STI

This infographic shares information regarding doxy PEP usage.

This video presentation by the San Francisco Department of Public Health (SFDPH) on implementation of Doxy-PEP in a single clinic which offered Doxy-PEP to all clients using HIV PrEP and saw bacterial STIs decrease among those who used Doxy-PEP by nearly 60% in less than a year, with the highest declines for syphilis (78%) and chlamydia (67%).

This guideline discusses the interim recommendations for the use of doxycycline for post-exposure prophylaxis (doxy PEP) for the prevention of certain bacterial sexually transmitted infections (STIs).

This fact sheet from the NYC Department of Health and Mental Hygiene discusses how Doxy PEP can be used for STI prevention.

This fact sheet discusses how doxy PEP can be used for STI prevention.

This webpage discusses how using doxycycline as STI PEP (post-exposure prophylaxis) is a new use for a well-known medication. Learn more about this new tool and how it's being used to prevent STIs!

This recorded presentation delves into the critical issue of STI disparities among adolescents in the Southern United States, a pressing public health concern with significant implications for health equity. Understanding these disparities is essential for developing effective interventions and policies to promote the well-being of marginalized communities. 

This video discusses how during the 2024 Conference on Retroviruses and Opportunistic Infections, Dr. John Brooks, Chief Medical Officer for CDC's Division of HIV Prevention, joins HIV.gov Director Miguel Gomez to share the latest information on mpox.

This video discusses how to talk about practicing safer sex with partners.

This guide discusses partner services for HIV and STDs and is targeted towards providers and other health professionals.